Systematic Financial Management LP Eli Lilly & CO Transaction History

Systematic Financial Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $17,641 - $21,850	-165 Closed	0 $0
Q3 2019 Nov 06, 2019	SELL	$106.79 - $116.16 $974,992 - $1.06 Million	-9,130 Reduced 98.22%	165 $18,000
Q2 2019 Jul 26, 2019	SELL	$110.79 - $129.32 $196,098 - $228,896	-1,770 Reduced 16.0%	9,295 $1.03 Million
Q1 2019 May 03, 2019	SELL	$111.31 - $131.02 $1.53 Million - $1.8 Million	-13,725 Reduced 55.37%	11,065 $1.44 Million
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $529,817 - $593,555	5,003 Added 25.28%	24,790 $2.87 Million
Q3 2018 Nov 06, 2018	BUY	$85.86 - $107.31 $1.7 Million - $2.12 Million	19,787 New	19,787 $2.12 Million
Q1 2018 May 09, 2018	SELL	$74.21 - $87.6 $1.35 Million - $1.6 Million	-18,235 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$81.94 - $87.89 $62,028 - $66,532	-757 Reduced 3.99%	18,235 $1.54 Million
Q3 2017 Nov 08, 2017	BUY	$77.07 - $85.54 $1.46 Million - $1.62 Million	18,992	18,992 $1.63 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Systematic Financial Management LP, based on Form 13F filings with the SEC.

Stay updated on Systematic Financial Management LP with notifications on news.